Meet some of the people behind SYSCID and learn more about their roles and achievements within the project

 

“The field of personalised medicine has to evolve in a manner that it really goes to the clinic.”

Philip Rosenstiel
Institute of Clinical Molecular
Biology (IKMB) / Kiel University, Germany

 

“All of the techniques that we use for the study of immune-mediated disease, we've been able to apply to the analysis of COVID-19.”

Paul Lyons
Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, UK

 

“One major achievement for us within SYSCID has been the standardisation of single-cell omics technologies for application in a clinical setting.”

Marc Beyer
German Center for Neurodegenerative Diseases (DZNE), Germany

 

“Now, the important thing would be how these signatures are to compare how these signatures are between populations and whether what we find in the European population can be applied to someone, for example, who is an Indian person.”

Neha Mishra
Institute of Clinical Molecular Biology (IKMB) / Kiel University, Germany

 

“For a clinician, it's very important to interact with the best scientists and to share with them the clinical problems and also learn from them how could somebody approach them in the lab.”

Dimitrios Boumpas
National and Kapodistrian University of Athens and Foundation for Biomedical Research at the Academy of Athens, Greece

 

“And I think this is very important to be able to have these internal discussions and the input that we give to each other's work. It's crucial to have a successful project.”

Joana Bernardes
Institute of Clinical Molecular Biology (IKMB) / Kiel University, Germany